Video

Allergan's dubious drug deal

Pharmaceutical company Allergan says it will transfer the patent to eye medication Restasis, to the Saint Regis Mohawk Tribe in a deal that Wall Street analysts call 'innovative' and tax efficient. But Bloomberg journalist Joe Nocera says it's nothing more than a "sleazy" way to block cheaper generic drugs
Pharmaceutical company Allergan says it will transfer the patent to eye medication Restasis, to the Saint Regis Mohawk Tribe in a deal that Wall Street analysts call 'innovative' and tax efficient. But Bloomberg journalist Joe Nocera says it's nothing more than a "sleazy" way to block cheaper generic drugs 6:50